AMGN vs MRNA
Amgen (AMGN) and Moderna (MRNA) compared side by side. Amgen (AMGN) is larger, with a market cap of $237.5B versus $79.9B for Moderna, about 3.0 times the size. MRNA returned +662.3% over the past year including dividends, versus +54.1% for AMGN, through October 23, 2026..
Head to head
| Metric | AMGN | MRNA |
|---|---|---|
| Market cap | $237.5B | $79.9B |
| P/E (TTM) | 27.3x | — |
| Forward P/E | 17.9x | -43.6x |
| Revenue (TTM) | $38.1B | $2.2B |
| Revenue growth | 9.5% | 2.1% |
| Gross margin | 71.9% | -66.0% |
| Operating margin | 35.5% | -557.9% |
| Free cash flow | $10.2B | -$1.2B |
| Dividend yield | 2.29% | None |
| 1-year return | +54.1% | +662.3% |
| 5-year return (annual) | +19.7% | -9.3% |
| Max drawdown | -78% | -95% |
| FI Handbook grade | B- | F |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$0
$10.0K
$20.0K
20222023202420252026
AMGN vs MRNA FAQ
Which is bigger, AMGN or MRNA?
Amgen (AMGN) is larger, with a market cap of $237.5B versus $79.9B for Moderna, about 3.0 times the size.
Which stock performed better over the past year, AMGN or MRNA?
MRNA returned +662.3% over the past year including dividends, versus +54.1% for AMGN, through October 23, 2026.
Which pays a higher dividend, AMGN or MRNA?
AMGN yields 2.29%; MRNA does not pay a dividend.